Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Paganelli

Showing results (51-60 of 213) with videos related to

Pageof 22
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 11, 2002
Poly(ethylene glycol)-avidin bioconjugates: suitable candidates for tumor pretargetingPaolo Caliceti, Marco Chinol, Marta Roldo, et al.
Thoracic Surgery Clinics|July 29, 2014
Peptide receptor radionuclide therapy for advanced neuroendocrine tumorsLisa Bodei, Marta Cremonesi, Mark Kidd, et al.
Annals of Surgery|January 25, 2008
Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 yearsMattia Intra, Nicole Rotmensz, Paolo Veronesi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2025
FAP inhibitors: are we really using the best method to evaluate the residence time?Michela Cortesi, Remo Guerrini, Chiara Roccatello, et al.
Cancer|December 22, 2004
Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institutionGiuseppe Viale, Stefano Zurrida, Eugenio Maiorano, et al.
The Breast Journal|November 19, 2013
Hibernoma mimicking metastasis on positron emission tomography-computed tomography imaging: a misleading finding in oncologic patient follow-upFrancesco Petrella, Cristina Noberasco, Lorenzo Monfardini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 13, 2006
Radiation protection in radionuclide therapies with (90)Y-conjugates: risks and safetyMarta Cremonesi, Mahila Ferrari, Giovanni Paganelli, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 6, 2012
Yttrium-labelled peptides for therapy of NETLisa Bodei, Marta Cremonesi, Chiara M Grana, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 5, 2006
Dosimetric model for locoregional treatments of brain tumors with 90Y-conjugates: clinical application with 90Y-DOTATOCMahila Ferrari, Marta Cremonesi, Mirco Bartolomei, et al.
Ecancermedicalscience|April 25, 2014
Atypical primary pulmonary meningioma: a report of a case suspected of being a lung metastasisDaniela Lepanto, Fausto Maffini, Francesco Petrella, et al.
Pageof 22

Showing results (51-60 of 213) with videos related to

Sort By:
Pageof 22
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 11, 2002
Poly(ethylene glycol)-avidin bioconjugates: suitable candidates for tumor pretargetingPaolo Caliceti, Marco Chinol, Marta Roldo, et al.
Thoracic Surgery Clinics|July 29, 2014
Peptide receptor radionuclide therapy for advanced neuroendocrine tumorsLisa Bodei, Marta Cremonesi, Mark Kidd, et al.
Annals of Surgery|January 25, 2008
Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 yearsMattia Intra, Nicole Rotmensz, Paolo Veronesi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2025
FAP inhibitors: are we really using the best method to evaluate the residence time?Michela Cortesi, Remo Guerrini, Chiara Roccatello, et al.
Cancer|December 22, 2004
Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institutionGiuseppe Viale, Stefano Zurrida, Eugenio Maiorano, et al.
The Breast Journal|November 19, 2013
Hibernoma mimicking metastasis on positron emission tomography-computed tomography imaging: a misleading finding in oncologic patient follow-upFrancesco Petrella, Cristina Noberasco, Lorenzo Monfardini, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 13, 2006
Radiation protection in radionuclide therapies with (90)Y-conjugates: risks and safetyMarta Cremonesi, Mahila Ferrari, Giovanni Paganelli, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 6, 2012
Yttrium-labelled peptides for therapy of NETLisa Bodei, Marta Cremonesi, Chiara M Grana, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 5, 2006
Dosimetric model for locoregional treatments of brain tumors with 90Y-conjugates: clinical application with 90Y-DOTATOCMahila Ferrari, Marta Cremonesi, Mirco Bartolomei, et al.
Ecancermedicalscience|April 25, 2014
Atypical primary pulmonary meningioma: a report of a case suspected of being a lung metastasisDaniela Lepanto, Fausto Maffini, Francesco Petrella, et al.
Pageof 22